Clinical significance of CD24 as a predictor of bladder cancer recurrence

Chunxiao Liu, Shaobo Zheng, Haiyan Shen, Kai Xu, Jie Chen, Hulin Li, Yawen Xu, Abai Xu, Binshen Chen, Haruki Kaku, Yasutomo Nasu, Hiromi Kumon, Peng Huang, Masami Watanabe

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cluster of differentiation (CD)24 was originally described as a B lymphocyte marker and has recently received considerable attention in cancer research as its overexpression has been observed in several types of carcinoma. The CD24 molecule is a glycosyl-phosphatidylinositol-linked cell surface protein that appears to be associated with aggressive cancers involving invasion and metastasis. However, the expression of CD24 in human bladder cancer and its clinical significance remains largely unknown and no association has been reported between CD24 overexpression and human bladder tumor recurrence. In the present study, the CD24 expression in cancer tissues obtained during transurethral surgery and the subsequent intra-bladder tumor recurrence following surgery were assessed. Immunohistochemical staining was performed and the intensity of CD24 staining was semi-quantitatively evaluated. CD24 expression was observed more frequently in high-grade bladder tumors (G2-G3) than low-grade tumors (G1). Positive CD24 expression was significantly associated with intra-bladder tumor recurrence following surgery and increased staining intensity was also correlated with recurrence. The positive association between CD24 expression and tumor recurrence was observed in each tumor category (stages Ta and T1, low and high grade). The results demonstrated that CD24 expression is significantly associated with bladder tumor recurrence. To the best of our knowledge, this is the first study to reveal the significance of CD24 as a predictor of bladder cancer recurrence. These insights may lead to future therapeutic strategies targeting CD24 to prevent the dissemination of bladder cancer cells and tumor recurrence.

Original languageEnglish
Pages (from-to)96-100
Number of pages5
JournalOncology Letters
Volume6
Issue number1
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Urinary Bladder Neoplasms
Recurrence
Neoplasms
Staining and Labeling
Glycosylphosphatidylinositols
Membrane Proteins
B-Lymphocytes
Neoplasm Metastasis
Carcinoma
Research

Keywords

  • Bladder cancer
  • CD24
  • Immunohistochemistry
  • Recurrence
  • Tumor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Clinical significance of CD24 as a predictor of bladder cancer recurrence. / Liu, Chunxiao; Zheng, Shaobo; Shen, Haiyan; Xu, Kai; Chen, Jie; Li, Hulin; Xu, Yawen; Xu, Abai; Chen, Binshen; Kaku, Haruki; Nasu, Yasutomo; Kumon, Hiromi; Huang, Peng; Watanabe, Masami.

In: Oncology Letters, Vol. 6, No. 1, 07.2013, p. 96-100.

Research output: Contribution to journalArticle

Liu, C, Zheng, S, Shen, H, Xu, K, Chen, J, Li, H, Xu, Y, Xu, A, Chen, B, Kaku, H, Nasu, Y, Kumon, H, Huang, P & Watanabe, M 2013, 'Clinical significance of CD24 as a predictor of bladder cancer recurrence', Oncology Letters, vol. 6, no. 1, pp. 96-100. https://doi.org/10.3892/ol.2013.1357
Liu, Chunxiao ; Zheng, Shaobo ; Shen, Haiyan ; Xu, Kai ; Chen, Jie ; Li, Hulin ; Xu, Yawen ; Xu, Abai ; Chen, Binshen ; Kaku, Haruki ; Nasu, Yasutomo ; Kumon, Hiromi ; Huang, Peng ; Watanabe, Masami. / Clinical significance of CD24 as a predictor of bladder cancer recurrence. In: Oncology Letters. 2013 ; Vol. 6, No. 1. pp. 96-100.
@article{b90a202b17264072bc5124424c9a9a8c,
title = "Clinical significance of CD24 as a predictor of bladder cancer recurrence",
abstract = "Cluster of differentiation (CD)24 was originally described as a B lymphocyte marker and has recently received considerable attention in cancer research as its overexpression has been observed in several types of carcinoma. The CD24 molecule is a glycosyl-phosphatidylinositol-linked cell surface protein that appears to be associated with aggressive cancers involving invasion and metastasis. However, the expression of CD24 in human bladder cancer and its clinical significance remains largely unknown and no association has been reported between CD24 overexpression and human bladder tumor recurrence. In the present study, the CD24 expression in cancer tissues obtained during transurethral surgery and the subsequent intra-bladder tumor recurrence following surgery were assessed. Immunohistochemical staining was performed and the intensity of CD24 staining was semi-quantitatively evaluated. CD24 expression was observed more frequently in high-grade bladder tumors (G2-G3) than low-grade tumors (G1). Positive CD24 expression was significantly associated with intra-bladder tumor recurrence following surgery and increased staining intensity was also correlated with recurrence. The positive association between CD24 expression and tumor recurrence was observed in each tumor category (stages Ta and T1, low and high grade). The results demonstrated that CD24 expression is significantly associated with bladder tumor recurrence. To the best of our knowledge, this is the first study to reveal the significance of CD24 as a predictor of bladder cancer recurrence. These insights may lead to future therapeutic strategies targeting CD24 to prevent the dissemination of bladder cancer cells and tumor recurrence.",
keywords = "Bladder cancer, CD24, Immunohistochemistry, Recurrence, Tumor",
author = "Chunxiao Liu and Shaobo Zheng and Haiyan Shen and Kai Xu and Jie Chen and Hulin Li and Yawen Xu and Abai Xu and Binshen Chen and Haruki Kaku and Yasutomo Nasu and Hiromi Kumon and Peng Huang and Masami Watanabe",
year = "2013",
month = "7",
doi = "10.3892/ol.2013.1357",
language = "English",
volume = "6",
pages = "96--100",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Clinical significance of CD24 as a predictor of bladder cancer recurrence

AU - Liu, Chunxiao

AU - Zheng, Shaobo

AU - Shen, Haiyan

AU - Xu, Kai

AU - Chen, Jie

AU - Li, Hulin

AU - Xu, Yawen

AU - Xu, Abai

AU - Chen, Binshen

AU - Kaku, Haruki

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Huang, Peng

AU - Watanabe, Masami

PY - 2013/7

Y1 - 2013/7

N2 - Cluster of differentiation (CD)24 was originally described as a B lymphocyte marker and has recently received considerable attention in cancer research as its overexpression has been observed in several types of carcinoma. The CD24 molecule is a glycosyl-phosphatidylinositol-linked cell surface protein that appears to be associated with aggressive cancers involving invasion and metastasis. However, the expression of CD24 in human bladder cancer and its clinical significance remains largely unknown and no association has been reported between CD24 overexpression and human bladder tumor recurrence. In the present study, the CD24 expression in cancer tissues obtained during transurethral surgery and the subsequent intra-bladder tumor recurrence following surgery were assessed. Immunohistochemical staining was performed and the intensity of CD24 staining was semi-quantitatively evaluated. CD24 expression was observed more frequently in high-grade bladder tumors (G2-G3) than low-grade tumors (G1). Positive CD24 expression was significantly associated with intra-bladder tumor recurrence following surgery and increased staining intensity was also correlated with recurrence. The positive association between CD24 expression and tumor recurrence was observed in each tumor category (stages Ta and T1, low and high grade). The results demonstrated that CD24 expression is significantly associated with bladder tumor recurrence. To the best of our knowledge, this is the first study to reveal the significance of CD24 as a predictor of bladder cancer recurrence. These insights may lead to future therapeutic strategies targeting CD24 to prevent the dissemination of bladder cancer cells and tumor recurrence.

AB - Cluster of differentiation (CD)24 was originally described as a B lymphocyte marker and has recently received considerable attention in cancer research as its overexpression has been observed in several types of carcinoma. The CD24 molecule is a glycosyl-phosphatidylinositol-linked cell surface protein that appears to be associated with aggressive cancers involving invasion and metastasis. However, the expression of CD24 in human bladder cancer and its clinical significance remains largely unknown and no association has been reported between CD24 overexpression and human bladder tumor recurrence. In the present study, the CD24 expression in cancer tissues obtained during transurethral surgery and the subsequent intra-bladder tumor recurrence following surgery were assessed. Immunohistochemical staining was performed and the intensity of CD24 staining was semi-quantitatively evaluated. CD24 expression was observed more frequently in high-grade bladder tumors (G2-G3) than low-grade tumors (G1). Positive CD24 expression was significantly associated with intra-bladder tumor recurrence following surgery and increased staining intensity was also correlated with recurrence. The positive association between CD24 expression and tumor recurrence was observed in each tumor category (stages Ta and T1, low and high grade). The results demonstrated that CD24 expression is significantly associated with bladder tumor recurrence. To the best of our knowledge, this is the first study to reveal the significance of CD24 as a predictor of bladder cancer recurrence. These insights may lead to future therapeutic strategies targeting CD24 to prevent the dissemination of bladder cancer cells and tumor recurrence.

KW - Bladder cancer

KW - CD24

KW - Immunohistochemistry

KW - Recurrence

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84878332878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878332878&partnerID=8YFLogxK

U2 - 10.3892/ol.2013.1357

DO - 10.3892/ol.2013.1357

M3 - Article

AN - SCOPUS:84878332878

VL - 6

SP - 96

EP - 100

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -